About this trial
To compare the efficacy and safety of ultrasound-guided ESPB versus QLB for post-operative analgesia in children undergoing kidney surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Infection at the site of needle insertion
Allergy to local anesthetics
Parental refusal of consent
Trial design
Parallel
Treatments tested in this trial
Quadratus lumborum block teqnique
Procedure/SurgeryAll blocks were performed under ultrasound guidance. A high-frequency linear probe was positioned in the mid-axillary line cranial to the iliac crest to identify the abdominal wall muscles (external oblique, internal oblique, and transversus abdominis). The probe was then moved dorsally until the transversus abdominis muscle became aponeurotic, which was followed medially to visualize the quadratus lumborum (QL) muscle at its attachment to the L4 transverse process adjacent to the psoas muscle. Using an in-plane anterior-to-posterior approach, the block needle was advanced toward the anterior border of the QL muscle. After confirming the needle tip position with a 1 ml saline test injection, 0.5 ml/kg of 0.25% bupivacaine was administered. Bilateral injections were performed for midline incisions, while unilateral injections were used for paramedian incisions.
Erector spinae plane block Technique
Procedure/SurgeryUltrasound-guided erector spinae plane block performed at the thoracic level using a single-shot technique in pediatric patients undergoing kidney surgery to provide postoperative analgesia. Local anesthetic is injected deep to the erector spinae muscle over the transverse process with expected craniocaudal spread.
Treatment groups
Trial outcomes
Primary outcomes
Time to first rescue analgesia
measured from extubation until the first request/administration of analgesia, in hours
Secondary outcomes
Total analgesic consumption
Total 24-hour postoperative analgesic consumption (mg/kg paracetamol, µg/kg fentanyl).
Postoperative pain score
FLACC pain score assessed at 0, 1, 2, 6, 12, and 24 hours postoperatively.
Incidence of postoperative nausea and vomiting
Incidence of PONV within 24 hours postoperatively.
Block-related complications
Incidence of block-related complications.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: